MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Dystonia gravidarum: An emerging clinical entity

E. Donlon, P. Moloney, S. Smyth, S. Lyons, T. Lynch, E. Mcgovern (Limerick, Ireland)

Meeting: MDS Virtual Congress 2021

Abstract Number: 118

Keywords: Botulinum toxin: Clinical applications: dystonia, Dystonia: Clinical features, Dystonia: Etiology and Pathogenesis

Category: Dystonia: Epidemiology, Genetics, Phenomenology

Objective: We describe a case of cervical dystonia in a 36 year-old, secundigravid, Caucasian woman at 8 weeks gestation.

Background: Though uncommon, primary movement disorders can occur in pregnancy, the most common being restless legs syndrome and chorea gravidarum [1]. new onset dystonia in pregnancy or dystonia gravidarum has been reported just 4 times previously [1,2]. Exacerbation of pre-existing movement disorders and onset of de novo movement disorders during pregnancy support the hypothesis that female sex hormones play an important role in regulation of basal ganglia circuitry.

Method: N/A

Results: A 36 year old right handed, secundigravid, Caucasian woman at 8 weeks gestation presented with involuntary movements of the head, neck and  right shoulder. Neurological examination revealed torticollis predominantly to the right, laterocollis to the left, and right shoulder elevation. The left sternocleidomastoid was hypertrophied. Treatment was initiated for presumed dystonia gravidarum with procyclidine and clonazepam. There was some improvement in severity of movements, but symptoms persisted throughout pregnancy. There was complete resolution of dystonia 3 days post-partum. The patient began breast feeding and once mature milk was produced the dystonic movements remerged, albeit less severe than during pregnancy. A 5 day hiatus of breast feeding led to a significant improvement in symptoms but not resolution. At this time botulinum toxin treatment was administered to the left and right SCM with good symptomatic improvement.

Conclusion: This is the 5th reported case of dystonia with onset during pregnancy and establishes DG as a distinct clinical entity. Based on the cases which have been reported in the literature to date, a distinct clinical phenotype along with a temporal course has emerged.The prompt improvement or resolution of symptoms after delivery strongly supports the hormonal milieu of pregnancy being the key driver of nigrostriatal dysfunction.

References: 1. Ba F, Miyasaki JM. Movement disorders in pregnancy. In: Handbook of Clinical Neurology. ; 2020. doi:10.1016/B978-0-444-64240-0.00013-1 2. Lim ECH, Seet RCS, Wilder-Smith E, Ong BKC. Dystonia gravidarum: A new entity? Mov Disord. 2006. doi:10.1002/mds.20648 3. Fasano A, Elia AE, Guidubaldi A, Tonali PA, Bentivoglio AR. Dystonia gravidarum: A new case with a long follow-up. Mov Disord. 2007. doi:10.1002/mds.21310

To cite this abstract in AMA style:

E. Donlon, P. Moloney, S. Smyth, S. Lyons, T. Lynch, E. Mcgovern. Dystonia gravidarum: An emerging clinical entity [abstract]. Mov Disord. 2021; 36 (suppl 1). https://www.mdsabstracts.org/abstract/dystonia-gravidarum-an-emerging-clinical-entity/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to MDS Virtual Congress 2021

MDS Abstracts - https://www.mdsabstracts.org/abstract/dystonia-gravidarum-an-emerging-clinical-entity/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley